FDA Inspection 1019351 — Cognitive Research Corporation
The FDA completed an inspection of Cognitive Research Corporation on July 14, 2017 in Saint Petersburg, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 14, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Saint Petersburg, FL (United States)
Additional Details
Sponsor, Contract Research Organization